$POAI BUY Trend up, consolidating sideways.AI Influenced, cancer stock, supported at levels and receiving volume. Buying 1/27 ASAP.
POAI trade ideas
AI HypeAI hype is scary real. I think AI is probably already hyping itself. Long live our new rulers.
A break above 0.53 would bring more strength. Pattern could be a rare Wolfe Wave. Time will tell.
POAI 15 min Scalpers editiontest
Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal and associated products. It operates through the following segments: Helomics, Skyline, Soluble, and Corporate. The Helomics segment includes clinical testing and contract research services that include the application of AI. The Skyline segment consists of the STREAMWAY System product sales, and its TumorGenesis subsidiary is included within corporate. The Soluble segment provides services using an automated system that conducts self-interaction chromatography screens, using additives and excipients commonly included in protein formulations resulting in soluble and physically stable formulations for biologics. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Eagan, MN.
POAI bullish wave 3 startedSeems we have corrected wave (2) now and subwave 1 of (3) is initiated
High risk trade
POAI 2HRtest
Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal and associated products. It operates through the following segments: Helomics, Skyline, Soluble, and Corporate. The Helomics segment includes clinical testing and contract research services that include the application of AI. The Skyline segment consists of the STREAMWAY System product sales, and its TumorGenesis subsidiary is included within corporate. The Soluble segment provides services using an automated system that conducts self-interaction chromatography screens, using additives and excipients commonly included in protein formulations resulting in soluble and physically stable formulations for biologics. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Eagan, MN.
POAI **ON WATCH** 88% BORROW RATEAll,
Add POAI to your watchlist and watch the borrow rate. It is currently sitting at 88% meaning a short squeeze could be imminent. Definitely have to be careful with short squeezes. Need breakouts, news, volume to pull of a short squeeze so sometimes these cheaper stocks with not so good or bad fundamentals without news won't ever break the trend. So just add a few alerts and add to watchlist. IF it does break could be a pretty large gain looks like 60%.
POAI moving above $1.06 towards $1.40The Hull Moving Average is following the Fib circles, the Chaikin Money Flow appears to be crossing up and the nice arc makes us think this stock is going LONG.
Some action is coming ?!#NewsPlay $POAI seems doesn't want to hit its support for this channel. Which is a very bullish signal.
Bollinger getting tight, RSI and MACD turning up and crossing (respectively).
Even Volume is coming. There may be some action very soon.
POAI Long IdeaPOAI, with price now above the supporting moving averages and moving higher this looks like a buy again. This could easily make a move for the 200sma above. MACD trending higher. I'd like more volume
